Recombinant AAV Integration Is Not Associated With Hepatic Genotoxicity in Nonhuman Primates and Patients.
暂无分享,去创建一个
J. Prieto | H. Petry | Valérie Ferreira | R. Fronza | G. González-Aseguinolaza | Manfred Schmidt | D. D’Avola | C. Kaeppel | A. Benito | Irene Gil-Farina | Esperanza López-Franco | J. Prieto | M. Schmidt | Christine Kaeppel
[1] D. Schaffer,et al. Genome Engineering Using Adeno-associated Virus: Basic and Clinical Research Applications. , 2016, Molecular therapy : the journal of the American Society of Gene Therapy.
[2] H. Büning,et al. Adeno-associated Vector Toxicity-To Be or Not to Be? , 2015, Molecular therapy : the journal of the American Society of Gene Therapy.
[3] Jessica Zucman-Rossi,et al. Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas , 2015, Nature Genetics.
[4] David Hurlbut,et al. Long-term correction of Sandhoff disease following intravenous delivery of rAAV9 to mouse neonates. , 2015, Molecular therapy : the journal of the American Society of Gene Therapy.
[5] A. Elkahloun,et al. Vector design influences hepatic genotoxicity after adeno-associated virus gene therapy. , 2015, The Journal of clinical investigation.
[6] R. Heilbronn,et al. Adeno-Associated Virus Type 2 Wild-Type and Vector-Mediated Genomic Integration Profiles of Human Diploid Fibroblasts Analyzed by Third-Generation PacBio DNA Sequencing , 2014, Journal of Virology.
[7] C. von Kalle,et al. Linear amplification mediated PCR--localization of genetic elements and characterization of unknown flanking DNA. , 2014, Journal of visualized experiments : JoVE.
[8] C. von Kalle,et al. Safety and liver transduction efficacy of rAAV5-cohPBGD in nonhuman primates: a potential therapy for acute intermittent porphyria. , 2013, Human gene therapy.
[9] Stephan Wolf,et al. A largely random AAV integration profile after LPLD gene therapy , 2013, Nature Medicine.
[10] F. Bushman,et al. Recombinant adeno-associated virus integration sites in murine liver after ornithine transcarbamylase gene correction. , 2013, Human gene therapy.
[11] K. L. La Perle,et al. Patterns of scAAV vector insertion associated with oncogenic events in a mouse model for genotoxicity. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.
[12] Pei-Rong Wang,et al. Induction of hepatocellular carcinoma by in vivo gene targeting , 2012, Proceedings of the National Academy of Sciences.
[13] Karine Tremblay,et al. Efficacy and long term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open label trial , 2012, Gene Therapy.
[14] Pratima Chowdary,et al. Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. , 2011, The New England journal of medicine.
[15] Namshin Kim,et al. Methodology and software to detect viral integration site hot-spots , 2011, BMC Bioinformatics.
[16] Hojun Li,et al. Assessing the potential for AAV vector genotoxicity in a murine model. , 2011, Blood.
[17] Shoshannah L. Roth,et al. A method to sequence and quantify DNA integration for monitoring outcome in gene therapy , 2011, Nucleic acids research.
[18] V. Haurigot,et al. Safety of AAV Factor IX Peripheral Transvenular Gene Delivery to Muscle in Hemophilia B Dogs , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[19] Jean Bennett,et al. Gene Therapy for Leber's Congenital Amaurosis is Safe and Effective Through 1.5 Years After Vector Administration , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.
[20] Kathleen A. Marshall,et al. Safety and efficacy of gene transfer for Leber's congenital amaurosis. , 2008, The New England journal of medicine.
[21] Hanno Glimm,et al. High-resolution insertion-site analysis by linear amplification–mediated PCR (LAM-PCR) , 2007, Nature Methods.
[22] Theresa A. Storm,et al. DNA Palindromes with a Modest Arm Length of ≳20 Base Pairs Are a Significant Target for Recombinant Adeno-Associated Virus Vector Integration in the Liver, Muscles, and Heart in Mice , 2007, Journal of Virology.
[23] Daniel G. Miller,et al. AAV Vector Integration Sites in Mouse Hepatocellular Carcinoma , 2007, Science.
[24] C. von Kalle,et al. Real-Time Definition of Non-Randomness in the Distribution of Genomic Events , 2007, PloS one.
[25] E. Furth,et al. Analysis of tumors arising in male B6C3F1 mice with and without AAV vector delivery to liver. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.
[26] Brian T Luke,et al. Redefining the common insertion site. , 2006, Virology.
[27] Daniel G. Miller,et al. Large-Scale Analysis of Adeno-Associated Virus Vector Integration Sites in Normal Human Cells , 2005, Journal of Virology.
[28] Theresa A. Storm,et al. Large-Scale Molecular Characterization of Adeno-Associated Virus Vector Integration in Mouse Liver , 2005, Journal of Virology.
[29] R. Samulski,et al. Integration of adeno-associated virus (AAV) and recombinant AAV vectors. , 2004, Annual review of genetics.
[30] Daniel G. Miller,et al. Adeno-associated virus vectors integrate at chromosome breakage sites , 2004, Nature Genetics.
[31] Daniel G. Miller,et al. Human Gene Targeting by Adeno-Associated Virus Vectors Is Enhanced by DNA Double-Strand Breaks , 2003, Molecular and Cellular Biology.
[32] Paul Shinn,et al. HIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots , 2002, Cell.
[33] A. Gibbs,et al. The Diagram, a Method for Comparing Sequences , 1970 .
[34] Manfred Schmidt,et al. Integration Frequency and Intermolecular Recombination of rAAV Vectors in Non-human Primate Skeletal Muscle and Liver. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.
[35] B. Fehse,et al. Retroviral integration site analysis in hematopoietic stem cells. , 2008, Methods in molecular biology.
[36] Theresa A. Storm,et al. DNA palindromes with a modest arm length of greater, similar 20 base pairs are a significant target for recombinant adeno-associated virus vector integration in the liver, muscles, and heart in mice. , 2007, Journal of virology.
[37] A. Gibbs,et al. The diagram, a method for comparing sequences. Its use with amino acid and nucleotide sequences. , 1970, European journal of biochemistry.